Variant report
Variant | nsv976596 |
---|---|
Chromosome Location | chr12:33138757-33140970 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:8)
- CpG islands (count:122)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:8 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr12:33140531-33140731 | K562 | blood: | n/a | n/a |
2 | JUND | chr12:33138830-33139012 | HepG2 | liver: | n/a | chr12:33138859-33138868 |
3 | MAFF | chr12:33139554-33139874 | HepG2 | liver: | n/a | chr12:33139709-33139727 |
4 | MAFF | chr12:33139647-33139771 | K562 | blood: | n/a | chr12:33139709-33139727 |
5 | MAFK | chr12:33139549-33139866 | HepG2 | liver: | n/a | chr12:33139711-33139727 chr12:33139711-33139722 chr12:33139711-33139722 chr12:33139711-33139726 |
6 | MAFK | chr12:33139706-33139735 | K562 | blood: | n/a | chr12:33139711-33139727 chr12:33139711-33139722 chr12:33139711-33139722 chr12:33139711-33139726 |
7 | MAFK | chr12:33139561-33139866 | IMR90 | lung: | n/a | chr12:33139711-33139727 chr12:33139711-33139722 chr12:33139711-33139722 chr12:33139711-33139726 |
8 | MAFK | chr12:33139551-33139883 | HepG2 | liver: | n/a | chr12:33139711-33139727 chr12:33139711-33139722 chr12:33139711-33139722 chr12:33139711-33139726 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:33139395-33139445 | NT2-D1 | testis: | n/a |
2 | chr12:33139435-33139485 | GM06990 | blood: | n/a |
3 | chr12:33139395-33139445 | HAEpiC | amniotic membrane: | n/a |
4 | chr12:33139395-33139445 | SK-N-MC | brain: | n/a |
5 | chr12:33139435-33139485 | AoSMC | blood vessel: | n/a |
6 | chr12:33139395-33139445 | HMEC | breast: | n/a |
7 | chr12:33139395-33139445 | AG04450 | lung: | fetal |
8 | chr12:33139395-33139445 | T-47D | breast: | n/a |
9 | chr12:33139395-33139445 | MCF-7 | breast: | n/a |
10 | chr12:33139435-33139485 | HAEpiC | amniotic membrane: | n/a |
11 | chr12:33139395-33139445 | ECC-1 | luminal epithelium: | n/a |
12 | chr12:33139435-33139485 | LNCaP | prostate: | n/a |
13 | chr12:33139435-33139485 | CMK | blood: | n/a |
14 | chr12:33139395-33139445 | PFSK-1 | brain: | n/a |
15 | chr12:33139435-33139485 | HPAEpiC | pulmonary alveolar: | n/a |
16 | chr12:33139435-33139485 | SK-N-SH_RA | brain: | n/a |
17 | chr12:33139435-33139485 | PFSK-1 | brain: | n/a |
18 | chr12:33139395-33139445 | HRPEpiC | eye: | n/a |
19 | chr12:33139395-33139445 | HL-60 | blood: | n/a |
20 | chr12:33139395-33139445 | HCPEpiC | choroid plexus: | n/a |
21 | chr12:33139435-33139485 | H1-hESC | embryonic stem cell: | embryo |
22 | chr12:33139395-33139445 | HIPEpiC | eye: | n/a |
23 | chr12:33139395-33139445 | HRCEpiC | kidney: | n/a |
24 | chr12:33139435-33139485 | HEK293 | kidney: | embryo |
25 | chr12:33139435-33139485 | Jurkat | blood: | n/a |
26 | chr12:33139395-33139445 | HEEpiC | esophagus: | n/a |
27 | chr12:33139395-33139445 | CMK | blood: | n/a |
28 | chr12:33139395-33139445 | SK-N-SH_RA | brain: | n/a |
29 | chr12:33139435-33139485 | MCF-7 | breast: | n/a |
30 | chr12:33139395-33139445 | K562 | blood: | n/a |
31 | chr12:33139395-33139445 | HUVEC | blood vessel: | n/a |
32 | chr12:33139435-33139485 | A549 | lung: | n/a |
33 | chr12:33139435-33139485 | ECC-1 | luminal epithelium: | n/a |
34 | chr12:33139395-33139445 | NB4 | blood: | n/a |
35 | chr12:33139435-33139485 | GM12891 | blood: | n/a |
36 | chr12:33139435-33139485 | AG09319 | gingival: | n/a |
37 | chr12:33139395-33139445 | AoSMC | blood vessel: | n/a |
38 | chr12:33139435-33139485 | SK-N-SH | brain: | n/a |
39 | chr12:33139435-33139485 | GM19239 | blood: | n/a |
40 | chr12:33139435-33139485 | HCT-116 | colon: | n/a |
41 | chr12:33139395-33139445 | Jurkat | blood: | n/a |
42 | chr12:33139395-33139445 | GM12878 | blood: | n/a |
43 | chr12:33139395-33139445 | PrEC | prostate: | n/a |
44 | chr12:33139435-33139485 | BE2_C | brain: | n/a |
45 | chr12:33139395-33139445 | HNPCEpiC | eye: | n/a |
46 | chr12:33139435-33139485 | HCM | heart: | n/a |
47 | chr12:33139435-33139485 | Caco-2 | colon: | n/a |
48 | chr12:33139435-33139485 | NB4 | blood: | n/a |
49 | chr12:33139395-33139445 | GM19239 | blood: | n/a |
50 | chr12:33139395-33139445 | HepG2 | liver: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000257435 | TF binding region |
ENSG00000257316 | TF binding region |
ENSG00000257435 | CpG island |
ENSG00000257316 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12231850 | chr12:33138770-33138771 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs555035849 | chr12:33138807-33138808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116556827 | chr12:33138828-33138829 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73307630 | chr12:33138830-33138831 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs558032559 | chr12:33138880-33138881 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs578130251 | chr12:33138926-33138927 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs540879752 | chr12:33138928-33138929 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs560812504 | chr12:33138968-33138969 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs187406605 | chr12:33139013-33139014 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs58488828 | chr12:33139015-33139016 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs12367772 | chr12:33139017-33139018 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs7305797 | chr12:33139027-33139028 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs531685969 | chr12:33139029-33139030 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs191521301 | chr12:33139047-33139048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144719613 | chr12:33139066-33139067 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533155867 | chr12:33139068-33139069 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546488316 | chr12:33139086-33139087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566470180 | chr12:33139092-33139093 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs570332602 | chr12:33139107-33139108 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528843951 | chr12:33139112-33139113 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547849617 | chr12:33139140-33139141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568850714 | chr12:33139178-33139179 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537501965 | chr12:33139181-33139182 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557835896 | chr12:33139192-33139193 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs147832074 | chr12:33139197-33139198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182906148 | chr12:33139229-33139230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs554487789 | chr12:33139230-33139231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs199886162 | chr12:33139245-33139246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7306057 | chr12:33139246-33139247 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs556251937 | chr12:33139252-33139253 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12578228 | chr12:33139261-33139262 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs545127294 | chr12:33139262-33139263 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565425447 | chr12:33139286-33139287 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188017858 | chr12:33139329-33139330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540072659 | chr12:33139333-33139334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs199948059 | chr12:33139342-33139343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs559937239 | chr12:33139343-33139344 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192291644 | chr12:33139395-33139396 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs7306202 | chr12:33139408-33139409 | Weak transcription Enhancers | CpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs568713163 | chr12:33139410-33139411 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs531380901 | chr12:33139419-33139420 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs551176330 | chr12:33139428-33139429 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs375075413 | chr12:33139435-33139436 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs534366494 | chr12:33139461-33139462 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs554381242 | chr12:33139462-33139463 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs567875972 | chr12:33139475-33139476 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs536908359 | chr12:33139496-33139497 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369240291 | chr12:33139534-33139535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs141319674 | chr12:33139535-33139536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs545425648 | chr12:33139539-33139540 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cancer | 21129771 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17899364 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Chordoma | 18071362 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 21272361 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:33136800-33138800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
2 | chr12:33137000-33141600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
3 | chr12:33137000-33142200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr12:33137200-33141400 | Weak transcription | Placenta | Placenta |
5 | chr12:33137200-33141600 | Weak transcription | H1 Cell Line | embryonic stem cell |
6 | chr12:33140200-33140400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr12:33140400-33140600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr12:33140400-33140600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr12:33140400-33144400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
10 | chr12:33140600-33140800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
11 | chr12:33140600-33140800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr12:33140600-33142000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr12:33140600-33164800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr12:33140800-33142000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
15 | chr12:33140800-33142200 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |